Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Seoulin Bioscience Co Ltd banner
S

Seoulin Bioscience Co Ltd
KOSDAQ:038070

Watchlist Manager
Seoulin Bioscience Co Ltd
KOSDAQ:038070
Watchlist
Price: 6 240 KRW -1.58% Market Closed
Market Cap: ₩56.8B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
3Y
-26%
5Y
+23%
10Y
+85%
Operating Income
+
3Y
-96%
5Y
-89%
10Y
-83%
Net Income
+
3Y
-75%
5Y
-50%
10Y
+9%

Earnings Waterfall
Seoulin Bioscience Co Ltd

Income Statement
Seoulin Bioscience Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
266
287
313
317
303
290
285
278
277
245
0
0
35
23
25
67
84
96
114
87
68
50
36
23
16
13
16
20
19
19
14
12
225
757
1 313
1 896
2 287
2 371
2 463
2 566
2 482
2 030
1 461
823
330
178
0
0
Revenue
42 196
N/A
39 501
-6%
36 059
-9%
34 861
-3%
37 662
+8%
37 754
+0%
39 682
+5%
41 538
+5%
41 628
+0%
42 045
+1%
43 482
+3%
44 315
+2%
44 889
+1%
46 698
+4%
44 937
-4%
44 437
-1%
42 619
-4%
42 318
-1%
43 513
+3%
47 445
+9%
49 877
+5%
51 232
+3%
51 701
+1%
50 757
-2%
54 410
+7%
57 042
+5%
58 350
+2%
62 520
+7%
65 085
+4%
67 802
+4%
75 217
+11%
80 331
+7%
80 539
+0%
89 475
+11%
103 586
+16%
103 570
0%
104 708
+1%
98 335
-6%
84 236
-14%
81 576
-3%
89 569
+10%
85 821
-4%
84 514
-2%
82 093
-3%
75 410
-8%
74 572
-1%
71 000
-5%
76 738
+8%
Gross Profit
Cost of Revenue
(30 306)
(28 170)
(23 806)
(22 780)
(24 915)
(26 062)
(27 739)
(29 615)
(29 930)
(30 200)
(31 771)
(32 367)
(32 174)
(33 276)
(31 428)
(30 816)
(29 812)
(29 777)
(30 712)
(33 492)
(35 434)
(36 665)
(37 263)
(36 955)
(40 545)
(42 403)
(43 712)
(46 871)
(48 519)
(50 284)
(55 730)
(59 662)
(59 435)
(66 695)
(78 626)
(79 491)
(80 360)
(74 517)
(63 993)
(61 321)
(69 649)
(68 132)
(65 805)
(64 124)
(56 431)
(55 827)
(54 196)
(58 819)
Gross Profit
11 891
N/A
11 331
-5%
12 253
+8%
12 081
-1%
12 747
+6%
11 692
-8%
11 942
+2%
11 922
0%
11 699
-2%
11 844
+1%
11 711
-1%
11 947
+2%
12 716
+6%
13 422
+6%
13 509
+1%
13 622
+1%
12 807
-6%
12 541
-2%
12 800
+2%
13 952
+9%
14 443
+4%
14 567
+1%
14 439
-1%
13 803
-4%
13 865
+0%
14 639
+6%
14 637
0%
15 648
+7%
16 566
+6%
17 518
+6%
19 488
+11%
20 670
+6%
21 104
+2%
22 780
+8%
24 961
+10%
24 079
-4%
24 349
+1%
23 818
-2%
20 243
-15%
20 255
+0%
19 921
-2%
17 689
-11%
18 709
+6%
17 969
-4%
18 980
+6%
18 745
-1%
16 804
-10%
17 919
+7%
Operating Income
Operating Expenses
(7 615)
(7 295)
(9 280)
(10 325)
(10 048)
(9 869)
(9 549)
(9 651)
(9 941)
(10 091)
(10 576)
(10 695)
(10 541)
(10 656)
(10 639)
(10 641)
(11 651)
(11 904)
(12 124)
(12 585)
(12 690)
(12 769)
(12 932)
(12 780)
(12 061)
(13 204)
(11 974)
(12 136)
(12 096)
(12 146)
(12 358)
(12 616)
(13 493)
(14 365)
(14 698)
(15 117)
(15 071)
(15 554)
(16 585)
(16 668)
(17 410)
(16 808)
(17 228)
(17 231)
(17 990)
(18 408)
(17 051)
(17 522)
Selling, General & Administrative
(8 367)
(7 118)
(7 925)
(8 601)
(8 496)
(8 410)
(8 120)
(8 255)
(8 609)
(8 822)
(9 215)
(9 380)
(9 113)
(9 115)
(9 229)
(9 123)
(9 869)
(10 034)
(10 029)
(10 406)
(10 459)
(10 536)
(10 690)
(10 591)
(10 065)
(10 188)
(9 976)
(9 959)
(9 907)
(10 008)
(10 273)
(10 654)
(11 587)
(12 512)
(12 943)
(13 441)
(13 382)
(13 784)
(14 737)
(14 689)
(15 445)
(14 828)
(15 187)
(15 012)
(15 528)
(15 855)
(14 549)
(15 174)
Research & Development
(1 046)
(596)
(768)
(945)
(744)
(654)
(630)
(591)
(566)
(550)
(644)
(661)
(795)
(910)
(834)
(857)
(998)
(983)
(1 086)
(1 126)
(1 190)
(1 183)
(1 184)
(1 135)
(955)
(985)
(955)
(1 077)
(998)
(970)
(916)
(809)
(787)
(755)
(742)
(753)
(870)
(904)
(906)
(890)
(785)
(738)
(818)
(961)
(1 214)
(1 378)
(1 331)
(1 247)
Depreciation & Amortization
(646)
(381)
(587)
(779)
(808)
(804)
(798)
(804)
(767)
(718)
(716)
(652)
(633)
(630)
(576)
(662)
(783)
(888)
(1 009)
(1 054)
(1 041)
(1 052)
(1 061)
(1 057)
(1 043)
(1 031)
(1 042)
(1 098)
(1 191)
(1 167)
(1 169)
(1 153)
(1 119)
(1 098)
(1 013)
(923)
(818)
(867)
(942)
(1 089)
(1 180)
(1 242)
(1 223)
(1 229)
(1 249)
(1 217)
(1 213)
(1 101)
Other Operating Expenses
2 444
800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
0
(1 000)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(30)
0
42
42
0
Operating Income
4 275
N/A
4 037
-6%
2 974
-26%
1 757
-41%
2 699
+54%
1 823
-32%
2 393
+31%
2 271
-5%
1 757
-23%
1 752
0%
1 134
-35%
1 252
+10%
2 175
+74%
2 766
+27%
2 869
+4%
2 979
+4%
1 156
-61%
636
-45%
676
+6%
1 366
+102%
1 753
+28%
1 796
+2%
1 505
-16%
1 022
-32%
1 803
+76%
1 435
-20%
2 664
+86%
3 514
+32%
4 470
+27%
5 372
+20%
7 130
+33%
8 054
+13%
7 610
-6%
8 414
+11%
10 263
+22%
8 961
-13%
9 278
+4%
8 264
-11%
3 658
-56%
3 587
-2%
2 511
-30%
881
-65%
1 482
+68%
737
-50%
989
+34%
337
-66%
(246)
N/A
397
N/A
Pre-Tax Income
Interest Income Expense
555
535
563
564
353
420
334
162
239
198
223
560
364
557
512
318
1 051
826
802
861
684
733
9 398
9 413
9 291
9 272
748
794
587
501
348
14 317
13 778
13 623
17 006
3 172
6 044
6 013
2 997
2 440
(2 117)
(1 613)
(1 708)
(1 108)
3 003
2 853
2 969
2 666
Non-Reccuring Items
(2)
(2)
0
0
(1)
0
0
0
(5)
(12)
(12)
(12)
(9)
(3)
(3)
(3)
(154)
(158)
(158)
(158)
(7)
(2)
(1 003)
(1 003)
(1 003)
0
0
0
0
(39)
(39)
(64)
(1 407)
(1 368)
(1 372)
(1 388)
(513)
(562)
(594)
(558)
(2 329)
(2 703)
(2 795)
(2 877)
(852)
(427)
(299)
(212)
Gain/Loss on Disposition of Assets
(20)
(13)
(31)
(39)
(48)
(50)
(51)
(46)
(31)
(26)
2 549
2 552
2 553
2 560
29
26
146
139
106
108
(9)
(5)
(347)
(352)
(354)
(350)
(8)
(3)
(1)
0
(1)
(0)
6
(57)
(57)
(57)
(1)
(0)
(6)
(5)
(31)
0
(39)
(39)
(14)
0
(0)
0
Total Other Income
272
161
438
131
115
182
(118)
(48)
227
252
237
209
45
7
396
570
625
794
819
871
1 016
1 036
1 137
1 021
922
749
649
714
726
701
634
522
351
446
441
(65)
(778)
(834)
(871)
(410)
38
278
636
673
429
276
(71)
(141)
Pre-Tax Income
5 081
N/A
4 717
-7%
3 943
-16%
2 412
-39%
3 117
+29%
2 376
-24%
2 559
+8%
2 338
-9%
2 188
-6%
2 163
-1%
4 129
+91%
4 559
+10%
5 128
+12%
5 885
+15%
3 801
-35%
3 889
+2%
2 824
-27%
2 237
-21%
2 247
+0%
3 050
+36%
3 437
+13%
3 558
+4%
10 692
+201%
10 103
-6%
10 659
+6%
11 105
+4%
4 052
-64%
5 018
+24%
5 782
+15%
6 534
+13%
8 073
+24%
22 829
+183%
20 338
-11%
21 059
+4%
26 281
+25%
10 624
-60%
14 029
+32%
12 881
-8%
5 184
-60%
5 054
-3%
(1 929)
N/A
(3 157)
-64%
(2 425)
+23%
(2 615)
-8%
3 556
N/A
3 038
-15%
2 352
-23%
2 710
+15%
Net Income
Tax Provision
(921)
(833)
(693)
(160)
(435)
(356)
(382)
(452)
(427)
(409)
(837)
(906)
(970)
(1 110)
(722)
(733)
(556)
(410)
(305)
(508)
(553)
(597)
(2 016)
(1 374)
(1 772)
(1 785)
(287)
(973)
(981)
(1 324)
(2 017)
(4 874)
(4 459)
(4 485)
(5 364)
(1 808)
(3 464)
(3 457)
(1 794)
(2 301)
(394)
(286)
(472)
(482)
(415)
(161)
(201)
(43)
Income from Continuing Operations
4 160
3 886
3 253
2 255
2 682
2 022
2 177
1 886
1 761
1 753
3 292
3 653
4 158
4 775
3 079
3 155
2 268
1 826
1 941
2 543
2 884
2 962
8 677
8 729
8 887
9 321
3 765
4 045
4 801
5 209
6 056
17 955
15 879
16 574
20 917
8 816
10 565
9 424
3 390
2 753
(2 323)
(3 444)
(2 897)
(3 097)
3 140
2 878
2 151
2 667
Income to Minority Interest
0
(25)
(28)
(12)
(14)
72
80
66
64
19
(62)
(54)
(85)
(65)
(72)
(147)
(207)
(286)
(227)
(228)
(259)
(321)
(330)
(138)
(3)
116
302
205
92
178
(132)
(251)
(179)
(413)
(421)
(205)
(433)
(172)
(61)
(63)
2 206
2 086
2 306
2 435
(226)
(151)
(305)
(546)
Net Income (Common)
4 160
N/A
3 861
-7%
3 225
-16%
2 243
-30%
2 668
+19%
2 094
-22%
2 258
+8%
1 953
-14%
1 825
-7%
1 773
-3%
3 230
+82%
3 600
+11%
4 073
+13%
4 711
+16%
3 008
-36%
3 008
N/A
2 061
-31%
1 540
-25%
1 714
+11%
2 315
+35%
2 625
+13%
2 641
+1%
8 346
+216%
8 590
+3%
8 884
+3%
9 436
+6%
4 067
-57%
4 250
+4%
4 893
+15%
5 386
+10%
5 933
+10%
17 712
+199%
15 589
-12%
16 164
+4%
20 525
+27%
8 611
-58%
10 159
+18%
9 288
-9%
3 328
-64%
2 719
-18%
(118)
N/A
(1 357)
-1 055%
(591)
+56%
(662)
-12%
2 914
N/A
2 726
-6%
1 846
-32%
2 121
+15%
EPS (Diluted)
486.44
N/A
451.45
-7%
377.13
-16%
262.29
-30%
329.99
+26%
244.87
-26%
254.77
+4%
226.42
-11%
220.71
-3%
201.08
-9%
356.73
+77%
397.04
+11%
449.1
+13%
522.4
+16%
329.36
-37%
328.44
0%
226.56
-31%
166.45
-27%
185.82
+12%
251.88
+36%
285.77
+13%
287.32
+1%
909.17
+216%
937.56
+3%
973.83
+4%
1 048.02
+8%
451.85
-57%
472.18
+4%
543.58
+15%
598.77
+10%
659.77
+10%
1 969.54
+199%
1 775.46
-10%
1 798.99
+1%
2 285.13
+27%
958.85
-58%
934.63
-3%
1 035.66
+11%
371.12
-64%
303.17
-18%
-13.42
N/A
-151.54
-1 029%
-65.91
+57%
-73.84
-12%
334.47
N/A
304.71
-9%
209.11
-31%
240.23
+15%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.